--- title: "RESMED INC (RMD) stock listing, news and investor profile" url: "https://aibio.space/companies/resmed/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "RESMED INC (NYSE: RMD), United States. Listing facts, related biotech companies and news on aibio.space." --- RMD RESMED INC NYSE · United States # RESMED INC (RMD) news RESMED INC is a public biotech or pharmaceutical company listed on NYSE under the ticker RMD, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest RESMED INC news We have not published a story on RESMED INC yet. When there is news, it will appear here. ## RESMED INC at a glance - **Ticker**: RMD - **Listing**: NYSE - **Country**: United States - **Cash, Sep 30, 2026**: $1.01 billion ### Related companies - [Autonomix Medical](https://aibio.space/companies/autonomix-medical/) NASDAQ: AMIX - [Solventum](https://aibio.space/companies/solventum/) NYSE: SOLV - [DEXCOM INC](https://aibio.space/companies/dexcom/) NASDAQ: DXCM - [Aclarion](https://aibio.space/companies/aclarion/) NASDAQ: ACON - [LEMAITRE VASCULAR INC](https://aibio.space/companies/lemaitre-vascular/) NASDAQ: LMAT - [Rafael Holdings](https://aibio.space/companies/rafael/) NYSE: RFL - [Heartflow](https://aibio.space/companies/heartflow/) NASDAQ: HTFL - [Fresenius SE & Co. KGaA](https://aibio.space/companies/fresenius-fsnuy/) OTC: FSNUY ### Also on NYSE - [AbbVie](https://aibio.space/companies/abbvie/) ABBV - [ZIMMER BIOMET HOLDINGS, INC.](https://aibio.space/companies/zimmer-biomet/) ZBH - [STERIS](https://aibio.space/companies/steris/) STE - [IQVIA HOLDINGS INC.](https://aibio.space/companies/iqvia/) IQV - [AGILENT TECHNOLOGIES, INC.](https://aibio.space/companies/agilent-technologies/) A - [SMITH & NEPHEW](https://aibio.space/companies/smith-nephew/) SNN ## What RESMED INC does ResMed is a global digital health company that designs AI-powered, cloud-connected medical devices and software to improve home healthcare. It began in 1989 with CPAP treatment for obstructive sleep apnea, the first successful non-invasive treatment for that condition, and it now offers diagnostic products, masks, ventilation devices and connected care software. In June 2026 it acquired Noctrix Health, which makes an FDA De Novo classified device for restless legs syndrome. In 2025 it acquired VirtuOx, a software-enabled independent diagnostic testing facility for in-home sleep and respiratory testing. ResMed operates two segments, Sleep and Breathing Health and Residential Care Software. Its software businesses include Brightree for durable medical equipment providers and MEDIFOX DAN for residential care in Germany. On June 30, 2026, it agreed to sell its MatrixCare business for $490 million in cash. The company says it employs approximately 11,370 people and sells in more than 140 countries. | Product or program | What it is | Stage | |---|---|---| | CPAP systems | Treatment for obstructive sleep apnea | | | Noctrix Health device | FDA De Novo classified device for restless legs syndrome | acquired June 2026 | | MatrixCare | Care management software for senior living, skilled nursing and home health | sale agreed for $490 million | | Brightree | Software for durable or home medical equipment providers | | | MEDIFOX DAN | Care management software for residential care providers in Germany | | Summarised from the company's [10-K filed Aug 13, 2026](https://www.sec.gov/Archives/edgar/data/943819/000094381926000047/rmd-20260630.htm). ## RESMED INC annual financials | Line | FY ended Jun 30, 2026 | FY ended Jun 30, 2025 | |---|---|---| | Research and development | [$378.3 million](https://www.sec.gov/Archives/edgar/data/943819/000094381926000047/) | [$331.3 million](https://www.sec.gov/Archives/edgar/data/943819/000094381926000047/) | | Net income (loss) | [$1.52 billion](https://www.sec.gov/Archives/edgar/data/943819/000094381926000047/) | [$1.40 billion](https://www.sec.gov/Archives/edgar/data/943819/000094381926000047/) | | Cash from operations | [$1.81 billion](https://www.sec.gov/Archives/edgar/data/943819/000094381926000047/) | [$1.75 billion](https://www.sec.gov/Archives/edgar/data/943819/000094381926000047/) | | Cash and equivalents | [$1.47 billion](https://www.sec.gov/Archives/edgar/data/943819/000094381926000089/) | [$1.21 billion](https://www.sec.gov/Archives/edgar/data/943819/000094381926000047/) | Latest balance sheet, Sep 30, 2026 (10-Q): cash and equivalents $1.01 billion. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about RESMED INC What is the ticker symbol of RESMED INC? RESMED INC trades under the ticker RMD on NYSE. Where is RESMED INC listed? RESMED INC is listed on NYSE. Which country or territory is RESMED INC listed under? Our directory records RESMED INC under United States. Does aibio.space cover RESMED INC? aibio.space lists RESMED INC among 2,820 public biotech companies and publishes its news here as stories appear. What does RESMED INC develop? ResMed is a global digital health company that designs AI-powered, cloud-connected medical devices and software to improve home healthcare. It began in 1989 with CPAP treatment for obstructive sleep apnea, the first successful non-invasive treatment for that condition, and it now offers diagnostic products, masks, ventilation devices and connected care software. What is CPAP systems from RESMED INC? CPAP systems: Treatment for obstructive sleep apnea What is Noctrix Health device from RESMED INC? Noctrix Health device: FDA De Novo classified device for restless legs syndrome Stage: acquired June 2026. Is RESMED INC profitable? RESMED INC reported net income of $1.52 billion for the fiscal year ended Jun 30, 2026, and generated $1.81 billion of cash from operations, per its annual report to the SEC. How much does RESMED INC spend on research and development? $378.3 million in the fiscal year ended Jun 30, 2026, per its annual report. How much cash does RESMED INC have? $1.01 billion in cash at Sep 30, 2026, per its 10-Q. ## Investor discussion: RESMED INC Members talk about RESMED INC (RMD). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at RESMED INC, newest first. Each line links the filing it comes from. 1. 2026-08-17 Legal Reported a change of independent auditor. SEC Form 8-K (Items 4.01,5.02,7.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/943819/000119312526354154/d292919dex991.htm) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NYSE:RMD on TradingView](https://www.tradingview.com/symbols/NYSE-RMD/). ## Listing details RESMED INC is a public biotech or pharmaceutical company listed on NYSE under the ticker RMD, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: RESMED INC - **Ticker**: RMD - **Listing**: NYSE - **Country or territory**: United States Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/resmed/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "RESMED INC (RMD) stock listing, news and investor profile", 2026-10-31, https://aibio.space/companies/resmed/